1Life Healthcare, Inc. ONEM
Set alert
16.47 0.00 0.00%
At close · Feb 21
15.98 Day range 16.57
52-week range unavailable
- Open
- 16.00
- Prev close
- 16.47
- Mkt cap
- 3.40B
- Vol
- 15.27M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 15.98
- High
- 16.57
- Forward P/E
- -14.97
- Beta
- 0.00
- Short ratio
- 6.23
- Inst. own
- 87.15%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 21, 2023
- 50-d avg
- 16.14
- 200-d avg
- 15.12
- 1y target
- 18.00
Analyst view
Consensus: hold
Hold
Price target (mean) 18.00
Ratings (-1m) 14 1 buy · 13 hold · 0 sell
- Strong buy0
- Buy1
- Hold13
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 14
- 2 months ago 14
- 3 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.40 | -0.48 – -0.29 | -0.47 | +14.9% | 312.58M | +23.0% | 3 |
| Next quarter | -0.38 | -0.51 – -0.26 | -0.48 | +20.8% | 326.71M | +27.7% | 3 |
| Current year | -1.58 | -1.97 – -1.09 | -2.02 | +21.8% | 1.31B | +25.7% | 4 |
| Next year | -1.10 | -1.42 – -0.55 | -1.58 | +30.4% | 1.66B | +26.1% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2022 | Credit Suisse | Downgrade | Outperform | Neutral |
| Aug 15, 2022 | Jefferies | Downgrade | Buy | Hold |
| Jul 27, 2022 | Stifel | Downgrade | Buy | Hold |
| Jul 25, 2022 | Truist Securities | Downgrade | Buy | Hold |
| Jul 22, 2022 | Deutsche Bank | Maintained | — | Hold |
| Jul 22, 2022 | Barclays | Downgrade | Overweight | Equal-Weight |
| Jul 22, 2022 | Citigroup | Downgrade | Buy | Neutral |
| Jul 22, 2022 | SVB Leerink | Maintained | — | Market Perform |
| Jul 22, 2022 | BTIG | Downgrade | Buy | Neutral |
| Jul 12, 2022 | Deutsche Bank | Downgrade | Buy | Hold |
| Jul 11, 2022 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Jul 7, 2022 | BTIG | Upgrade | Neutral | Buy |
| May 27, 2022 | Stifel | Initiated | — | Buy |
| May 9, 2022 | SVB Leerink | Maintained | — | Market Perform |
| May 5, 2022 | Citigroup | Maintained | — | Buy |
| Mar 30, 2022 | Guggenheim | Initiated | — | Neutral |
| Feb 25, 2022 | Deutsche Bank | Maintained | — | Buy |
| Feb 24, 2022 | Morgan Stanley | Maintained | — | Overweight |
| Feb 24, 2022 | Piper Sandler | Maintained | — | Overweight |
| Feb 24, 2022 | SVB Leerink | Maintained | — | Market Perform |
| Feb 24, 2022 | Keybanc | Maintained | — | Overweight |
| Dec 21, 2021 | JP Morgan | Maintained | — | Overweight |
| Dec 15, 2021 | Credit Suisse | Maintained | — | Outperform |
| Nov 9, 2021 | SVB Leerink | Maintained | — | Market Perform |
| Nov 4, 2021 | Keybanc | Maintained | — | Overweight |
| Sep 27, 2021 | SVB Leerink | Initiated | — | Market Perform |
| Aug 12, 2021 | Barclays | Initiated | — | Overweight |
| Aug 9, 2021 | Baird | Downgrade | Outperform | Neutral |
| Aug 5, 2021 | Canaccord Genuity | Maintained | — | Buy |
| Aug 5, 2021 | Keybanc | Maintained | — | Overweight |